# Depocyt® With Sorafenib in Neoplastic Meningitis

> **NCT00964743** · NA · TERMINATED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 2 (actual)

## Conditions studied

- Neoplastic Meningitis

## Interventions

- **DRUG:** DepoCyt
- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT00964743
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Low Accrual
- **Last updated:** 2013-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00964743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00964743, "Depocyt® With Sorafenib in Neoplastic Meningitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00964743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*